Substance Use Disorder (SUD) Education: DEA Requirement

Beginning on June 27, 2023, the DEA requires a one-time attestation of training on management of substance use disorders (SUDs) prior to renewal of a DEA registration.  

SUD

The DEA has released guidance on the new one-time requirement for completion of eight hours of training on the treatment and management of patients with opioid or other SUDs. 

As an ACCME-accredited CME provider with Commendation, ACP offers a wide variety of recommended activities that count toward meeting the new DEA attestation requirement.

Choose from the curated list below to satisfy the completion of a minimum eight hours of substance use disorder CME.

Featured Education

ACP Pain Management 7: Opioid Use Disorder 5 CME

This interactive training module provides background information necessary to support clinicians in their care for persons with opioid use disorder (OUD), including persons with coexisting chronic pain. 

Begin

Xylazine Adulteration of the Heroin–Fentanyl Drug Supply, A Narrative Review 0.5 CME

Clinical experience along with the available pertinent research were used to review Xylazine, an animal sedative, and provide guidance on the care of patients exposed to Xylazine, published in Annals of Internal Medicine. After reading the article, follow instructions on the Point-of-Care CME page to claim credit.

Begin

SUD Presentations from 2023 Internal Medicine Meeting 2.5 CME

Captured from Internal Medicine Meeting 2023, this video bundle package provides 2.5 hours of high-yield video content covering strategies and management options for treating substance use disorder.

Begin

X-Express: The ABCs of Prescribing Buprenorphine 1 CME

This highly practical one-hour video course provides an overview of the role buprenorphine plays in the management of opioid use disorder.

Begin

Education By Format Type

Additional substance use disorder education can be found in ACP's Online Learning Center.

Frequently Asked Questions